top of page

JULY 2023

VascVersa secure Invest NI funding

VascVersa have been awarded Invest NI funding. This support from Invest NI will allow us to strengthen our Angicyte portfolio and complete a comprehensive analysis of the clinical grade product. We will work with Queen’s University Belfast for genomic analysis and support.

bottom of page